| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.038 | 0.8 |